Theravance Inc (THRX.OQ)

THRX.OQ on NASDAQ Stock Exchange Global Select Market

17.17USD
4:00pm EDT
Price Change (% chg)

$0.19 (+1.12%)
Prev Close
$16.98
Open
$17.19
Day's High
$17.51
Day's Low
$16.91
Volume
298,243
Avg. Vol
250,860
52-wk High
$32.87
52-wk Low
$15.81

THRX.OQ

Chart for THRX.OQ

About

Theravance, Inc. (Theravance) is a biopharmaceutical company with a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies. The Company is focused on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including... (more)

Overall

Beta: 1.85
Market Cap (Mil.): $1,952.94
Shares Outstanding (Mil.): 115.01
Dividend: 0.25
Yield (%): 5.89

Financials

  THRX.OQ Industry Sector
P/E (TTM): -- 32.88 33.65
EPS (TTM): -1.23 -- --
ROI: -23.97 18.21 17.48
ROE: -- 18.89 18.31
Search Stocks

BRIEF-GSK and Theravance says gains approval in Japan for Anoro Ellipta

* Press_release:anoro ellipta(umeclidinium/vilant erol) gains approval in Japan for the treatment of COPD

04 Jul 2014

BRIEF-GSK, Theravance submit sNDA to U.S. FDA for Breo Ellipta

* GSK and Theravance announce submission to US regulatory authorities for Fluticasone Furoate/Vilanterol in asthma

30 Jun 2014

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks